These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 32923657)
21. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging". Meftahi GH; Jangravi Z; Sahraei H; Bahari Z Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477 [TBL] [Abstract][Full Text] [Related]
22. Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials. Horowitz RI; Freeman PR Med Hypotheses; 2020 Oct; 143():109851. PubMed ID: 32534175 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study. Grumet M; Sherman J; Dorf BS Stem Cells Transl Med; 2022 Nov; 11(11):1103-1112. PubMed ID: 36181766 [TBL] [Abstract][Full Text] [Related]
24. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm. Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557 [TBL] [Abstract][Full Text] [Related]
25. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations. Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346 [No Abstract] [Full Text] [Related]
26. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction. Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317 [TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection. Hassan Kalantar Neyestanaki M; Gholizadeh O; Hosseini Tabatabaie F; Akbarzadeh S; Yasamineh S; Afkhami H; Sedighi S Virusdisease; 2024 Jun; 35(2):342-356. PubMed ID: 39071880 [TBL] [Abstract][Full Text] [Related]
28. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. Root-Bernstein R Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738 [TBL] [Abstract][Full Text] [Related]
29. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19. Talukdar J; Bhadra B; Dattaroy T; Nagle V; Dasgupta S Biomed Pharmacother; 2020 Dec; 132():110886. PubMed ID: 33113418 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile. Vatsalya V; Li F; Frimodig JC; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ medRxiv; 2020 Aug; ():. PubMed ID: 32869036 [TBL] [Abstract][Full Text] [Related]
31. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. Quirch M; Lee J; Rehman S J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537 [TBL] [Abstract][Full Text] [Related]
32. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911 [TBL] [Abstract][Full Text] [Related]
33. Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019. Bifulco M; Fiore D; Piscopo C; Gazzerro P; Proto MC Front Pharmacol; 2021; 12():631646. PubMed ID: 33912048 [No Abstract] [Full Text] [Related]
34. The COVID-19 Cytokine Storm; What We Know So Far. Ragab D; Salah Eldin H; Taeimah M; Khattab R; Salem R Front Immunol; 2020; 11():1446. PubMed ID: 32612617 [TBL] [Abstract][Full Text] [Related]
35. The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection. Jahani Sherafat S; Mokmeli S; Rostami-Nejad M; Razaghi Z; Rezaei Tavirani M; Razzaghi M J Lasers Med Sci; 2020; 11(Suppl 1):S23-S29. PubMed ID: 33995965 [No Abstract] [Full Text] [Related]
36. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients. Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810 [No Abstract] [Full Text] [Related]
37. Can steroids reverse the severe COVID-19 induced "cytokine storm"? Kolilekas L; Loverdos K; Giannakaki S; Vlassi L; Levounets A; Zervas E; Gaga M J Med Virol; 2020 Nov; 92(11):2866-2869. PubMed ID: 32530507 [TBL] [Abstract][Full Text] [Related]
38. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection. Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833 [TBL] [Abstract][Full Text] [Related]
39. Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines. Yu Q; Zhou X; Kapini R; Arsecularatne A; Song W; Li C; Liu Y; Ren J; Münch G; Liu J; Chang D Medicines (Basel); 2024 Jul; 11(7):. PubMed ID: 39051370 [TBL] [Abstract][Full Text] [Related]
40. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]